Adaptive mutability of colorectal cancers in response to targeted therapies

The emergence of drug resistance limits the efficacy of targeted therapies in human tumors. The prevalent view is that resistance is a fait accompli: when treatment is initiated, cancers already contain drug-resistant mutant cells. Bacteria exposed to antibiotics transiently increase their mutation...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Science (American Association for the Advancement of Science) Jg. 366; H. 6472; S. 1473
Hauptverfasser:	Russo, Mariangela, Crisafulli, Giovanni, Sogari, Alberto, Reilly, Nicole M, Arena, Sabrina, Lamba, Simona, Bartolini, Alice, Amodio, Vito, Magrì, Alessandro, Novara, Luca, Sarotto, Ivana, Nagel, Zachary D, Piett, Cortt G, Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore, Bertotti, Andrea, Trusolino, Livio, Corigliano, Mattia, Gherardi, Marco, Lagomarsino, Marco Cosentino, Di Nicolantonio, Federica, Bardelli, Alberto
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 20.12.2019
Schlagworte:	Adaptation, Biological - genetics Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics DNA Mismatch Repair - genetics Down-Regulation Drug Resistance, Neoplasm - genetics ErbB Receptors - antagonists & inhibitors Humans Molecular Targeted Therapy Mutagenesis Proto-Oncogene Proteins B-raf - antagonists & inhibitors Selection, Genetic
ISSN:	1095-9203, 1095-9203
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!